The Latest: US to buy initial antibody doses from Eli Lilly
|
October 28, 2020 9:06 AM
WASHINGTON -- The U.S. government has agreed to buy initial doses of an experimental COVID-19 antibody drug from Eli Lilly that patients could receive if federal regulators allow it on an emergency basis.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
